**Core Concept**
In pre-eclampsia, a hypertensive disorder of pregnancy, multiple laboratory and clinical parameters are monitored to assess maternal and fetal well-being. The condition is characterized by elevated blood pressure and the presence of proteinuria, with potential progression to severe features like eclampsia, hepatic dysfunction, and thrombocytopenia.

**Why the Correct Answer is Right**
Uric acid levels rise due to reduced renal clearance and increased metabolic demand, serving as a marker of severe disease. Platelet count is monitored because thrombocytopenia is a key feature, increasing the risk of bleeding complications. Liver function tests (LFTs) are assessed due to potential hepatic involvement, such as elevated transaminases. Thus, all listed parameters are clinically relevant in the management of pre-eclampsia.

**Why Each Wrong Option is Incorrect**
Option A: Uric acid is not routinely monitored in routine care but is a useful marker of severity, so it is not excluded.
Option B: Platelet count is a critical parameter, and its reduction is a known risk factor for complications.
Option C: LFTs are monitored due to the risk of liver dysfunction in severe pre-eclampsia.

**Clinical Pearl / High-Yield Fact**
In pre-eclampsia, a drop in platelets and rising liver enzymes or uric acid signal worsening disease — early detection of these markers helps guide delivery decisions and prevent progression to eclampsia.

✓ Correct Answer: D. All of the above